This content has been archived. It may no longer be relevant
We have recently seen pharmaceutical giants leave PhRMA, so what does it mean? PhRMA (Pharmaceutical Research and Manufacturers of America) is a trade association representing the leading biopharmaceutical research companies in the United States. When a pharmaceutical company leaves the trade organization, it means that the company has decided to withdraw its membership.
Companies choose to leave PhRMA for various reasons. For example, a company may disagree with the organization/s policies or positions on certain issues, such as drug pricing or intellectual property rights. Alternatively, a company may decide to leave to avoid paying membership dues or to pursue a different approach to advocacy and lobbying.
Leaving PhRMA does not necessarily mean that a pharmaceutical company will stop conducting research or producing drugs. It simply means that the company will no longer be a part of trade organization and will not benefit from the advocacy and lobbying efforts that PhRMA undertakes on behalf of its members. However, the company may choose to join other trade organizations or advocacy groups that align more closely with its interests and priorities.